Astrocyte Pharmaceuticals Hits Milestones: Phase 2 Trial, $3M NIH
17 Jun 2025 //
GLOBENEWSWIRE
Astrocyte Announces FDA Clearance of its Investigational NDA for AST-004
12 Mar 2024 //
GLOBENEWSWIRE
Alzheimer`s Drug Discovery Foundation Joins Astrocyte’s $6M Financing Round
18 Aug 2023 //
BUSINESSWIRE
Astrocyte Announces Theodore Liston, Ph.D., Vice President of Research
10 Apr 2023 //
BUSINESSWIRE
Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004
05 Apr 2023 //
BUSINESSWIRE
Astrocyte Pharma Presents Update on AST-004 Clinical Program at 2022 Symposium
14 Sep 2022 //
BUSINESSWIRE